141
Views
246
CrossRef citations to date
0
Altmetric
Cell and Organelle Structure and Assembly

Prohibitins Regulate Membrane Protein Degradation by the m-AAA Protease in Mitochondria

, &
Pages 3435-3442 | Received 09 Dec 1998, Accepted 30 Jan 1999, Published online: 28 Mar 2023
 

Abstract

Prohibitins comprise a protein family in eukaryotic cells with potential roles in senescence and tumor suppression. Phb1p and Phb2p, members of the prohibitin family in Saccharomyces cerevisiae, have been implicated in the regulation of the replicative life span of the cells and in the maintenance of mitochondrial morphology. The functional activities of these proteins, however, have not been elucidated. We demonstrate here that prohibitins regulate the turnover of membrane proteins by the m-AAA protease, a conserved ATP-dependent protease in the inner membrane of mitochondria. The m-AAA protease is composed of the homologous subunits Yta10p (Afg3p) and Yta12p (Rca1p). Deletion of PHB1 or PHB2 impairs growth of Δyta10 or Δyta12 cells but does not affect cell growth in the presence of the m-AAA protease. A prohibitin complex with a native molecular mass of approximately 2 MDa containing Phb1p and Phb2p forms a supercomplex with the m-AAA protease. Proteolysis of nonassembled inner membrane proteins by the m-AAA protease is accelerated in mitochondria lacking Phb1p or Phb2p, indicating a negative regulatory effect of prohibitins on m-AAA protease activity. These results functionally link members of two conserved protein families in eukaryotes to the degradation of membrane proteins in mitochondria.

ACKNOWLEDGMENTS

We thank B. Guiard for the COX4 disruption construct, S. Ackermann for the Δatp10 strain, A. Tzagoloff for critically reading the manuscript, and P. Coates for yeast strains and stimulating discussions during early phases of the project. The technical assistance of Petra Robisch and Alexandra Stiegler is gratefully acknowledged.

This work was supported by grants from the Deutsche Forschungsgemeinschaft (La918/1-2; SFB 184/B21) and the Medizinische Wochenschrift to T.L.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.